These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7995329)

  • 21. The influence of cholestyramine on the elimination of tenoxicam and piroxicam.
    Guentert TW; Defoin R; Mosberg H
    Eur J Clin Pharmacol; 1988; 34(3):283-9. PubMed ID: 3260866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tenoxicam on nociceptive thalamic neuronal firing in arthritic rats.
    Braga PC; Biella G; Tiengo M
    Drugs Exp Clin Res; 1987; 13(7):389-98. PubMed ID: 3498616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of tenoxicam on biochemical serum parameters of rats.
    Göker B; Yurtsever E; Sener A
    Drug Metabol Drug Interact; 1999; 15(2-3):207-14. PubMed ID: 10707126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic vasodilatation and renal sodium excretion: effects of hydralazine and diazoxide.
    Green TP
    Life Sci; 1984 May; 34(22):2169-76. PubMed ID: 6727558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human serum albumin conformational changes as induced by tenoxicam and modified by simultaneous diazepam binding.
    Brée F; Urien S; Nguyen P; Tillement JP; Steiner A; Vallat-Molliet C; Testa B; Visy J; Simonyi M
    J Pharm Pharmacol; 1993 Dec; 45(12):1050-3. PubMed ID: 7908973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of tenoxicam on abdominal wall healing: experimental study in rats].
    Watanabe AL; Watanabe LM
    Acta Cir Bras; 2005; 20(2):140-3. PubMed ID: 15884714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
    Perpignano G; Bogliolo A; Puccetti L
    Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
    Pratz J; Mondot S; Montier F; Cavero I
    J Pharmacol Exp Ther; 1991 Jul; 258(1):216-22. PubMed ID: 1906538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
    Day RO; Williams KM; Graham S; Handel M
    Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro synergistic effect of fluconazole with nonsteroidal anti-inflammatory agents against Candida albicans strains.
    Yücesoy M; Oktem IM; Gülay Z
    J Chemother; 2000 Oct; 12(5):385-9. PubMed ID: 11128557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of tenoxicam in healthy human volunteers.
    Heintz RC; Guentert TW; Enrico JF; Dubach UC; Brandt R; Jeunet FS
    Eur J Rheumatol Inflamm; 1984; 7(2):33-44. PubMed ID: 6336292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intra-articular injection of tenoxicam in rats: assessment of the local effects on the articular cartilage and synovium.
    Ozyuvaci H; Bilgic B; Ozyuvaci E; Altan A; Altug T; Karaca C
    J Int Med Res; 2004; 32(3):312-6. PubMed ID: 15174225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photosensitivity to piroxicam: absence of cross-reaction with tenoxicam.
    Gonçalo M; Figueiredo A; Tavares P; Ribeiro CA; Teixeira F; Baptista AP
    Contact Dermatitis; 1992 Nov; 27(5):287-90. PubMed ID: 1493681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single and multiple dose pharmacokinetics of tenoxicam in the elderly.
    Nilsen OG; Walstad RA; Eckert M; Heizmann P; Bückert A; Am T; Løge I; Unnvik J; Thue E
    Eur J Clin Pharmacol; 1988; 35(5):563-6. PubMed ID: 3266152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenoxicam: acute dose-dependent disposition studies in rats.
    Lopez-Bustamante LG; Troconiz JI; Fos D
    J Pharm Sci; 1993 Aug; 82(8):851-3. PubMed ID: 8377127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-performance liquid chromatographic analysis of piroxicam and tenoxicam in plasma, blood and buffer solution. Application to pharmacokinetic studies in small laboratory animals.
    Troconiz JI; Lopez-Bustamante LG; Fos D
    Arzneimittelforschung; 1993 Jun; 43(6):679-81. PubMed ID: 8352822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of diclofenac and tenoxicam on distraction osteogenesis.
    Sen C; Erdem M; Gunes T; Koseoglu D; Filiz NO
    Arch Orthop Trauma Surg; 2007 Apr; 127(3):153-9. PubMed ID: 17203285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ro 12-0068 (tenoxicam) in the treatment of extra-articular inflammatory processes.
    Fiszman P; Perpétuo JB; Sidi A
    Eur J Rheumatol Inflamm; 1985; 8(1):15-20. PubMed ID: 3915883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of some anti-inflammatory drugs on human neutrophil chemotaxis.
    Hasçelik G; Sener B; Hasçelik Z
    J Int Med Res; 1994; 22(2):100-6. PubMed ID: 8020636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.